圣诺医药-B(02257.HK)：殷惠军获委任为非执行董事

Group 1 - The company announced the resignation of Huang Mengying from various positions including independent non-executive director and chairman of the board, effective December 1, 2025, to focus on decentralized life sciences and expand her law firm in China [1] - Yin Huijun has been appointed as a non-executive director effective September 1, 2025 [1] - Lu Yixing has been appointed as an independent non-executive director effective September 1, 2025 [1] - The current executive director and CEO, Pan Honghui, will become the chairman of the board effective December 1, 2025 [1]